CLOPINASE AP 150 TABLET

Product Description

CLOPINASE AP 150 TABLET is a potent dual antiplatelet formulation combining Clopidogrel 75 mg and Aspirin 150 mg, designed to effectively reduce the risk of heart attack, stroke, and other cardiovascular events. Engineered with pellet-based technology for enhanced bioavailability and gastric protection, this tablet is ideal for long-term cardiac care.

Manufactured in WHO-GMP certified facilities, CLOPINASE AP 150 meets the highest quality standards, making it a reliable choice for cardiology departments, hospital pharmacies, and bulk pharmaceutical procurement.

Key Benefits:

• Dual-action formula for comprehensive antiplatelet therapy

• Enteric-coated pellets minimize gastric irritation

• Supports post-angioplasty and post-MI management

• Ensures optimal platelet inhibition with improved patient compliance

Applications:

• Secondary prevention of myocardial infarction (MI) and ischemic stroke

• Used in acute coronary syndrome (ACS) and post-cardiac intervention therapy

• Essential in cardiology treatment protocols and long-term vascular care